NASDAQ:ICAD
icad inc. Stock News
$1.19
-0.0750 (-5.93%)
At Close: Jul 02, 2024
Newly Launched ProFound Cloud Delivers Radiologists Cost-Effective, Secure, and Scalable Access to iCAD's Breast Health Suite of AI Solutions Newly Launched ProFound Cloud Delivers Radiologists Cost-E
iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference
08:00am, Tuesday, 04'th Jun 2024
NASHUA, N.H., June 04, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health
3 Top Small-Cap Growth Opportunities in the AI Era
07:00am, Friday, 17'th May 2024
It's certainly a very good time to be in the AI business. After all, the technology has been getting huge amounts of positive publicity since December 2022, and it's being viewed as a powerful, helpfu
iCAD Reports Financial Results for First Quarter Ended March 31, 2024
08:00am, Wednesday, 15'th May 2024
NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health
UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024
09:49am, Wednesday, 08'th May 2024
NASHUA, N.H., May 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results
iCAD to Report First Quarter 2024 Financial Results on May 15, 2024
08:00am, Thursday, 02'nd May 2024
NASHUA, N.H., May 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results
NASHUA, N.H., April 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will showcase its ProFound Br
NASHUA, N.H. and HALIFAX, Nova Scotia, April 09, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc . (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced a strategic
Study confirms iCAD's Breast Arterial Calcification AI Algorithm successfully detects calcification of breast vessels, an indicator of cardiovascular disease, from mammograms Study confirms iCAD's Bre
iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
08:00am, Tuesday, 02'nd Apr 2024
ProFound Cloud redefines accessibility to critical insights, empowering radiologists in early breast cancer detection ProFound Cloud redefines accessibility to critical insights, empowering radiologis
Artificial Intelligence, Real Profits: 3 Stocks to Outsmart the Market
02:00pm, Thursday, 14'th Mar 2024
The market is overlooking many stocks that could benefit from the proliferation of AI over the longer term. There are companies using AI to solve real-world problems, and others providing the raw mate
iCAD, Inc. (ICAD) Q4 2023 Earnings Call Transcript
10:59pm, Tuesday, 12'th Mar 2024
iCAD, Inc. (ICAD) Q4 2023 Earnings Call Transcript
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
04:01pm, Tuesday, 12'th Mar 2024
Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-year Full-Year Operating Cash Flow ($5) million vs. ($12.8) million prior year Year ending cash balance of $21.7M
The Hot List: 3 AI Stocks Worth Buying on Weakness
07:30am, Friday, 01'st Mar 2024
Wall Street has correctly recognized that artificial intelligence (AI) is a game-changer. It enables individuals to use computers more easily than ever before to find the best answers to complex quest
NASHUA, N.H., Feb. 28, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect canc